(Q36936989)

17 August 2017

1 reference

title

CE in anticancer metallodrug research--an update (English)

1 reference

17 August 2017

1

1 reference

17 August 2017

Bernhard K Keppler

2

0 references

publication date

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

28

1 reference

17 August 2017

3436-3446

1 reference

17 August 2017

19

1 reference

Tumour-inhibiting platinum(II) complexes with aminoalcohol ligands: biologically important transformations studied by micellar electrokinetic chromatography, nuclear magnetic resonance spectroscopy and mass spectrometry

17 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

Ruthenium complexes as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Recent developments in the field of tumor-inhibiting metal complexes.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Tumour-inhibiting platinum complexes--state of the art and future perspectives.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Gallium in cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Protein-binding Properties of two Antitumour Ru(III) Complexes to Human Apotransferrin and Apolactoferrin

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

[Ru(η6-p-cymene)Cl2(pta)] (pta = 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane): a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Classical and Non-Classical Ruthenium-Based Anticancer Drugs: Towards Targeted Chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Metal-based antitumour drugs in the post genomic era.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Capillary electrophoresis in anti-cancer metallodrug research: advances and future challenges

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Analysis of platinum adducts with DNA nucleotides and nucleosides by capillary electrophoresis coupled to ESI-MS: indications of guanosine 5'-monophosphate O6-N7 chelation

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Determination of binding constants and stoichiometries for platinum anticancer drugs and serum transport proteins by capillary electrophoresis using the Hummel-Dreyer method.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Determination of cisplatin and its hydrolytic metabolite in human serum by capillary electrophoresis techniques.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Multiplicity of metal ion binding patterns to nucleobases

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

A third mode of DNA binding: Phosphate clamps by a polynuclear platinum complex

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Why does Cisplatin reach Guanine-n7 with competing s-donor ligands available in the cell?

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Analysis of anticancer platinum(II)-complexes by microemulsion electrokinetic chromatography: separation of diastereomers and estimation of octanol-water partition coefficients

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Synthesis and biological activity of water-soluble maleimide derivatives of the anticancer drug carboplatin designed as albumin-binding prodrugs

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Pharmaceutical strategies utilizing recombinant human serum albumin

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Drug targeting with nano-sized carrier systems

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Polymer therapeutics: concepts and applications

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Tumor-inhibiting platinum(II) complexes with aminoalcohol ligands: comparison of the mode of action by capillary electrophoresis and electrospray ionization-mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Synthesis, crystal structure and pH dependent cytotoxicity of (SP-4-2)-bis(2-aminoethanolato-κ2N,O)platinum(II) – a representative of novel pH sensitive anticancer platinum complexes

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

DNA Interactions of pH-Sensitive, Antitumor Bis(aminoalcohol)dichloroplatinum(II) Complexes†,‡

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albumin.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Characterization of interactions between human serum albumin and tumor-inhibiting amino alcohol platinum(II) complexes using capillary electrophoresis.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Mono- and polynuclear [alkylamine]platinum(II) complexes of [1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II): synthesis and investigations on cytotoxicity, cellular distribution, and DNA and protein binding

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Structure and unique interactions with DNA of a cationic trans-platinum complex with the nonplanar bicyclic piperidinopiperidine ligand

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

trans-Platinum planar amine compounds with [N2O2] ligand donor sets: effects of carboxylate leaving groups and steric hindrance on chemical and biological properties

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Reversion of Structure-Activity Relationships of Antitumor Platinum Complexes by Acetoxime but Not Hydroxylamine Ligands

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Non-platinum chemotherapeutic metallopharmaceuticals

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Redox behavior of tumor-inhibiting ruthenium(iii) complexes and effects of physiological reductants on their binding to GMP

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Comparative binding of antitumor indazolium [trans-tetrachlorobis(1H-indazole)ruthenate(III)] to serum transport proteins assayed by capillary zone electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Platinum group metallodrug-protein binding studies by capillary electrophoresis - inductively coupled plasma-mass spectrometry: a further insight into the reactivity of a novel antitumor ruthenium(III) complex toward human serum proteins.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins--significance for the patient

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Receptor-mediated endocytosis: the intracellular journey of transferrin and its receptor

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Probing the stability of serum protein–ruthenium(III) drug adducts in the presence of extracellular reductants using CE

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and anti

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Determination of sulfur and selected trace elements in metallothionein-like proteins using capillary electrophoresis hyphenated to inductively coupled plasma mass spectrometry with an octopole reaction cell.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Hyphenated techniques for elemental speciation in biological systems

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Two dimensional separation schemes for investigation of the interaction of an anticancer ruthenium(iii) compound with plasma proteins

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700114

7 January 2021

Identifiers

DOI

10.1002/ELPS.200700114

1 reference

17 August 2017

1 reference

PubMed ID

17847132